Research Abstract
The laboratory is involved in studies of 1) human genetic polymorphisms including the MHC, 2) genetics of life span 3) genetics of drug induced hematopoetic complications and 4) genetics of the progression of clinical tuberculosis.
Edmond J. Yunis, M.D.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Phone: (617) 632-3343
Fax: (617) 632-4466
Edmond J. Yunis, M.D.
Dana-Farber Cancer Institute
EDUCATIONAL TITLES
Publications from Harvard Catalyst Profiles
- Szilágyi A, Bánlaki Z, Pozsonyi E, Yunis EJ, Awdeh ZL, Hossó A, Rajczy K, Larsen CE, Fici DA, Alper CA, Füst G. Frequent occurrence of conserved extended haplotypes (CEHs) in two Caucasian populations. Mol Immunol 2010; 47:1899-904. PubMed
- Zúñiga J, Romero V, Azocar J, Terreros D, Vargas-Rojas MI, Torres-GarcÃa D, Jiménez-Alvarez L, Vargas-Alarcón G, Granados-Montiel J, Husain Z, Chung RT, Alper CA, Yunis EJ. Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol 2009; 46:2723-7. PubMed
- Cantu de Leon D,Perez-Montiel D,Villavicencio V,Garcia Carranca A,Mohar Betancourt A,Acuna-Alonzo V,Lopez-Tello A,Vargas-Alarcon G,Barquera R,Yu N,Yunis EJ,Granados J. High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 2009; 9:48. PubMed
- Romero V, Azocar J, Zuniga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung RT, Amos C, Yunis EJ. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 2008; 45:2429-36. PubMed